NHS England has recently unveiled its ambitious 10-Year Health Plan, a detailed and comprehensive strategy outlining how the healthcare system intends to transform health provision, infrastructure, and patient outcomes across England by the year 2035. The sweeping blueprint proposes major structural overhauls designed to modernise the NHS, reduce institutional strain, and pivot from a reactive treatment model toward a proactive, preventative system of care. For the Tuberous Sclerosis Complex (TSC) community—individuals, families, and caregivers navigating a complex, multi-system rare genetic condition—this landmark policy document carries significant implications. While the proposals introduce promising pathways toward more integrated local care, advanced digital health records, cutting-edge diagnostics, and enhanced mental health support, they also raise critical questions regarding implementation, rare disease representation, and accessibility for vulnerable patient groups.
More Integrated and Local Care
At the heart of the newly unveiled 10-year strategy is a fundamental geographical and operational shift in how healthcare is delivered, moving support away from overstretched centralized hospitals and into community-based settings. NHS England has branded this vision the “Neighbourhood Health Service.” The overarching objective of this transformation is to ensure that patients receive more personalized, accessible care closer to their permanent places of residence. Rather than navigating the often exhausting process of traveling to major hospital complexes for routine checks, patients may soon attend appointments in local health centres and community hubs designed to operate for extended hours—specifically, at least 12 hours a day, six days a week.
NHS England anticipates that decentralizing routine services will foster a more preventative approach to healthcare, enabling medical professionals to catch developing issues before they escalate into major medical emergencies. Furthermore, the model aims to streamline patient pathways and alleviate mounting waiting times across the board.
For the TSC community, this localized approach could alleviate some of the heavy logistical burdens associated with managing a lifelong, multi-system condition. Patients and families often find themselves juggling a dizzying array of hospital appointments across different departments and facilities. Under a truly integrated neighbourhood model, individuals might no longer have to travel vast distances or coordinate disjointed schedules for routine TSC check-ups and diagnostic scans. Moreover, the structural emphasis on localized, community-based multidisciplinary teams should encourage different healthcare professionals to work much more closely alongside one another, cultivating a deeper, more cohesive understanding of each patient’s unique and multifaceted health needs.
A Greater Focus on the NHS App
Digital modernization represents another core pillar of the 10-Year Health Plan, with the official NHS App slated for substantial technological enhancements over the coming decade. The upgraded platform is intended to serve as a comprehensive digital front door for patients, facilitating much easier management of medical appointments, prescription orders, and routine health administration. Crucially, the plan promises individuals secure, streamlined access to their own comprehensive medical records, paving the way for clearer, more direct communication between patients and their healthcare providers.
For individuals living with TSC, the digitization of health records addresses a persistent and frustrating hurdle. Because TSC can affect multiple organ systems—including the brain, kidneys, heart, skin, and lungs—patients frequently accumulate fragmented medical histories scattered across numerous clinical departments and disparate hospitals. This information silo effect can make it exceptionally difficult for patients, families, and even clinicians to track symptoms and treatment histories accurately.
While easier digital access to medical records holds immense potential for improving care continuity, the TSA notes that significant practical questions remain regarding inclusivity and accessibility. A major concern for the TSC community centers on usability, particularly for individuals who rely heavily on family members or professional caregivers to manage their healthcare. It remains entirely unclear how the enhanced NHS App will accommodate proxy access—whether caregivers will be granted seamless, secure permission to view, manage, and interact with the medical records of the vulnerable adults or children they support on a daily basis. Without robust provisions for assisted digital access, these technological upgrades risk inadvertently marginalizing the very patients who require the most coordinated support.
Improved Access to Specialist Treatments
Innovation forms a cornerstone of the long-term vision, with the strategy placing heavy emphasis on harnessing cutting-edge technologies, particularly genomics and artificial intelligence (AI), to personalize treatments and accurately predict individual health risks. NHS England has set out an ambitious goal to position the nation as a global leader in genomics, aiming to roll out universal newborn genomic testing by the year 2030. Concurrently, artificial intelligence is envisioned to act as a dependable “trusted assistant” for clinicians, helping to streamline workflows and maximize the clinical impact of treatments.
For the TSC community, the integration of advanced genomics and AI introduces a mixture of cautious optimism and unanswered questions. While the practical execution of these technologies within the NHS still requires substantial clarification, the potential benefits are profound. Earlier genomic sequencing in newborns could lead to significantly earlier diagnoses of rare conditions like TSC, enabling medical teams to intervene and initiate supportive care much sooner in a child’s life. For adults already living with TSC, advanced analytics and AI could improve ongoing symptom management and disease monitoring. There is also the tantalizing prospect that machine learning algorithms might eventually recognize subtle physiological patterns or early indicators of TSC progression that current diagnostic methods fail to detect. Nevertheless, the TSC community awaits concrete details on how these high-tech interventions will be funded, regulated, and equitably distributed across standard clinical practice.
A Stronger Focus on Prevention and Early Intervention
For decades, the operational framework of NHS England has been predominantly reactive—responding to medical crises after they have manifested, rather than intercepting them beforehand. For instance, in the context of TSC, clinical intervention often occurs only after a TSC-related tumor has grown to a size that begins compressing surrounding tissue, impairing organ function, or otherwise causing acute clinical complications. The 10-Year Health Plan articulates a decisive policy pivot toward proactive prevention, underpinned by predictive healthcare analytics, wearable technologies, and continuous remote patient monitoring devices. The overarching hope is that continuous tracking will empower the health service to identify physiological deterioration and intervene long before conditions escalate into severe crises.
This shift toward continuous monitoring is particularly relevant for managing the unpredictable trajectory of Tuberous Sclerosis Complex. The clinical manifestation of TSC is known to evolve significantly over time; a prime example is the development of TSC-associated renal angiomyolipomas—growths in the kidneys—which can emerge later in life even in individuals who have never previously experienced kidney-related complications. If the NHS successfully transitions to a preventative model capable of tracking subtle changes in the body through continuous monitoring and responsive local diagnostics, these renal growths could potentially be identified while they are still extremely small. Catching such developments early could vastly improve the efficacy of interventions designed to halt or diminish disease progression, sparing patients from invasive surgeries and long-term organ damage.
Better Mental Health Support
Recognizing historical gaps in provision, the 10-Year Health Plan includes a firm pledge for substantial financial and structural investment in mental health care. The strategy outlines the expansion of dedicated mental health emergency services, round-the-clock virtual access to qualified therapists for individuals experiencing mild to moderate psychological distress, and simplified pathways for mental health self-referral. Additionally, the plan commits to expanding specialized mental health support teams within schools, ensuring that children and adolescents can access psychological assistance during their formative years. NHS England projects that these expanded community and virtual resources will accelerate specialist care access while simultaneously relieving immense, unsustainable pressure on hospital Accident and Emergency departments.
For individuals within the TSC community, this renewed focus on mental health is both welcome and urgently needed. It is now widely recognized that Tuberous Sclerosis Complex-Associated Neuropsychiatric Conditions—collectively known as TAND—represent a profound and pervasive challenge for a vast portion of the TSC population, impacting behavior, cognition, and emotional well-being. Despite the high prevalence and severity of TAND, patients and families have historically faced severe barriers when attempting to access appropriate, specialized psychological support through the public health system. The promised enhancements in mental health infrastructure offer hope for more equitable, timely, and impactful psychological services for people living with TSC across England.
The TSA’s View on the 10-Year Health Plan
The Tuberous Sclerosis Association maintains that the current health system in England frequently falls short of providing adequate, coordinated support for everyone living with TSC. Viewed against this backdrop, the ambitious 10-Year Health Plan represents a substantial opportunity to improve healthcare access, management, and long-term outcomes for individuals and families affected by the condition. In particular, the strategic emphasis on integrated, local care—if successfully executed—could dismantle the persistent barriers caused by communication silos between disparate clinical specialists, creating a positive domino effect of improved lifelong health management.
At the same time, the charity sounds a pragmatic note of caution regarding the gap between political ambition and operational reality. Writing visionary plans on paper is a straightforward exercise, but the true test lies in transforming those written aspirations into tangible, everyday improvements for patients. The TSA welcomes the direction of the plan but eagerly awaits concrete proof that its promises will be fully realized rather than quietly diluted over the coming decade.
Furthermore, the charity highlights a glaring and deeply concerning omission within the overarching strategy document: the plan is frustratingly light in its discussion of rare diseases. Across the entire length of the comprehensive report, the word “rare” appears a mere eight times—a statistic that the TSA considers completely unacceptable given the collective millions of individuals in the UK living with rare and complex conditions. As these sweeping reforms move forward, the charity has made clear its intention to utilize every available resource to hold NHS England strictly accountable to the commitments and hopes outlined in the new agreement.
